These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31777307)

  • 1. Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer.
    Wang B; Zhang W; Zhou X; Liu M; Hou X; Cheng Z; Chen D
    Drug Deliv; 2019 Dec; 26(1):1265-1279. PubMed ID: 31777307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel multifunctional triple folic acid, biotin and CD44 targeting pH-sensitive nano-actiniaes for breast cancer combinational therapy.
    Liu M; Wang B; Guo C; Hou X; Cheng Z; Chen D
    Drug Deliv; 2019 Dec; 26(1):1002-1016. PubMed ID: 31571501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.
    Fang L; Zhang W; Wang Z; Fan X; Cheng Z; Hou X; Chen D
    Drug Deliv; 2019 Dec; 26(1):1125-1139. PubMed ID: 31736389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition.
    Chen D; Lian S; Sun J; Liu Z; Zhao F; Jiang Y; Gao M; Sun K; Liu W; Fu F
    Drug Deliv; 2016; 23(3):808-13. PubMed ID: 24892632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer.
    Wang K; Guo C; Dong X; Yu Y; Wang B; Liu W; Chen D
    Mol Pharm; 2018 Jul; 15(7):2764-2769. PubMed ID: 29792799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation.
    Dong X; Zou S; Guo C; Wang K; Zhao F; Fan H; Yin J; Chen D
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):168-177. PubMed ID: 29239219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel dual ROS-sensitive and CD44 receptor targeting nanomicelles based on oligomeric hyaluronic acid for the efficient therapy of atherosclerosis.
    Hou X; Lin H; Zhou X; Cheng Z; Li Y; Liu X; Zhao F; Zhu Y; Zhang P; Chen D
    Carbohydr Polym; 2020 Mar; 232():115787. PubMed ID: 31952595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization and in vitro/in vivo evaluation of novel reduction-sensitive hybrid nano-echinus-like nanomedicine.
    Wang K; Guo C; Zou S; Yu Y; Fan X; Wang B; Liu M; Fang L; Chen D
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):659-667. PubMed ID: 29703084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy.
    Xi Y; Jiang T; Yu Y; Yu J; Xue M; Xu N; Wen J; Wang W; He H; Shen Y; Chen D; Ye X; Webster TJ
    Int J Nanomedicine; 2019; 14():6425-6437. PubMed ID: 31496695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
    Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
    Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
    Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
    Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Mitochondrial Targeting Multifunctional Surface Charge-Reversal Polymeric Nanoparticles for Cancer Treatment.
    Fang L; Fan H; Guo C; Cui L; Zhang P; Mu H; Xu H; Zhao F; Chen D
    J Biomed Nanotechnol; 2019 Nov; 15(11):2151-2163. PubMed ID: 31847930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Dual Mitochondrial and CD44 Receptor Targeting Nanoparticles for Redox Stimuli-Triggered Release.
    Wang K; Qi M; Guo C; Yu Y; Wang B; Fang L; Liu M; Wang Z; Fan X; Chen D
    Nanoscale Res Lett; 2018 Feb; 13(1):32. PubMed ID: 29396830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of dissolving hyaluronic acid composite microneedles loaded micelles for delivery of curcumin.
    Cheng Z; Lin H; Wang Z; Yang X; Zhang M; Liu X; Wang B; Wu Z; Chen D
    Drug Deliv Transl Res; 2020 Oct; 10(5):1520-1530. PubMed ID: 32100266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of octreotide-modified curcumin plus docetaxel micelles for potential treatment of non-small-cell lung cancer.
    An Q; Shi CX; Guo H; Xie SM; Yang YY; Liu YN; Liu ZH; Zhou CZ; Niu FJ
    Pharm Dev Technol; 2019 Nov; 24(9):1164-1174. PubMed ID: 31340709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
    Wang J; Li Y; Wang L; Wang X; Tu P
    Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-modified didecyldimethylammonium bromide/ d-a-tocopheryl polyethylene glycol succinate mixed micelles for delivery of baohuoside I against non-small cell lung cancer: in vitro and in vivo evaluation.
    Yan H; Song J; Jia X; Zhang Z
    Drug Deliv; 2017 Nov; 24(1):30-39. PubMed ID: 28155337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo.
    Wang P; Zhang L; Peng H; Li Y; Xiong J; Xu Z
    Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4802-8. PubMed ID: 24094190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines.
    Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Biomed Pharmacother; 2020 May; 125():109988. PubMed ID: 32059173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.